IFS software used by Cadillac Formula 1® Team to support multiple areas of the Team’s operations Partnership to showcase the power of IFS and include key brand placements for IFS across Cadillac Formula 1® Team assets DALLAS and SILVERSTONE, England, Jan. 7, 2026 /PRNewswire/ — IFS, the leading provider of Industrial software, today announces a strategic… Continue reading Cadillac Formula 1® Team Partners with IFS Ahead of the Team’s Debut Season
Tag: Morgan
Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference
BREA, Calif., Jan. 7, 2026 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, from 3:45 – 4:25 pm PST. A live audio webcast of the event will be available in… Continue reading Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference
AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., Jan. 7, 2026 /PRNewswire/ — Amgen (NASDAQ:AMGN) will present at the 2026 J.P. Morgan Healthcare Conference at 3:45 p.m. PT on Monday, January 12, 2026. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be… Continue reading AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Cetera Chief Operating Officer Tom Gooley to Retire Following Planned Transition
Retirement caps a high-impact career that delivered innovation, efficiency and leadership continuity, all while forming a strong foundation for what’s next at Cetera SAN DIEGO, Jan. 7, 2026 /PRNewswire/ — Cetera today announced that Chief Operating Officer Tom Gooley plans to retire following a patiently planned transition. Gooley’s retirement marks the culmination of a successful… Continue reading Cetera Chief Operating Officer Tom Gooley to Retire Following Planned Transition
Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 7, 2026 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company’s president and CEO, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 14,… Continue reading Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference
Sensura to Showcase Non-Invasive Health Monitoring Platform, Starting with Glucose, at CES 2026
LAS VEGAS, Jan. 6, 2026 /PRNewswire/ — Sensura, a Singapore-based deep-tech company focused on next-generation health and wellness monitoring, today announced that it will showcase its non-invasive health monitoring platform, starting with glucose, at CES 2026, taking place from January 6–9, 2026, in Las Vegas. Sensura will be exhibiting at Booth 35301, Hall 2. Continue Reading Sensura… Continue reading Sensura to Showcase Non-Invasive Health Monitoring Platform, Starting with Glucose, at CES 2026
Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies
CHENGDU, China, Jan. 6, 2026 /PRNewswire/ — The 44th J.P. Morgan Healthcare Conference (JPMHC) will be held in San Francisco, California, USA, from January 12 to 15, 2026. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech” or the “Company”, 6990.HK) has been invited to attend the conference and Dr. Michael Ge, President and CEO of Kelun-Biotech, will… Continue reading Kelun-Biotech to Attend the 44th J.P. Morgan Healthcare Conference, Sharing Its Business Progresses and Innovation Strategies
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ — Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer and Hyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco, California on January 12–15, 2026. Celltrion’s presentation and fireside chat are scheduled… Continue reading Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
TOKYO, Jan. 6, 2026 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, Calif. As a global leader in life sciences, Astellas will use this premier platform to highlight its key… Continue reading Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
SHANGHAI, Jan. 5, 2026 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will present a company update and that the management team including chairman Bill Wu and Chief… Continue reading Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference